Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Strides Pharma to sell Australian business for Rs 1900 crore

      Strides Pharma to sell Australian business for Rs 1900 crore

      Farhat Nasim1 July 2019 12:40 PM IST
      Earlier this year, Strides Pharma Science had decided to exit its investment in Arrow Pharmaceuticals for AUD 394 million (approx Rs 1,900 crore).NEW...
      Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

      Alembic Pharma gets USFDA nod for Clonazepam orally disintegrating tablets

      Farhat Nasim1 July 2019 12:25 PM IST
      The approval from the United States Food and Drug Administration (USFDA) is for the company's abbreviated new drug application (ANDA) for Clonazepam...
      Fortis Healthcare Case: SEBI partially modifies order against Religare Finvest

      Fortis Healthcare Case: SEBI partially modifies order against Religare Finvest

      Farhat Nasim1 July 2019 11:31 AM IST
      In the matter of Fortis Healthcare, SEBI recently noted that the proposed measures like the restructuring of RFL's debt, assignment of its gross...
      India witnessing inflow of medical tourists from UAE, Gulf region

      India witnessing inflow of medical tourists from UAE, Gulf region

      Farhat Nasim1 July 2019 9:30 AM IST
      New Delhi: India has been witnessing an increasing influx of medical tourists from across the world, including the United Arab Emirates and the Gulf...
      NPPA fixes ceiling price of painkiller, tetanus injections; Details

      NPPA fixes ceiling price of painkiller, tetanus injections; Details

      Farhat Nasim30 Jun 2019 11:00 AM IST
      New Delhi: Through a recent notification, the drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the ceiling...
      Oxytocin for domestic use to madatorily bear barcodes- Minister informs Parliament

      Oxytocin for domestic use to madatorily bear barcodes- Minister informs Parliament

      Farhat Nasim30 Jun 2019 10:00 AM IST
      The manufacture of Oxytocin formulations for domestic use shall be by public sector undertakings or companies only and the label of the product shall...
      True North sells Aster DM Healthcare stake worth Rs 448 crore

      True North sells Aster DM Healthcare stake worth Rs 448 crore

      Farhat Nasim30 Jun 2019 9:18 AM IST
      According to the shareholding pattern available on BSE NSE 0.03 %, at the end of March quarter, True North III A, held 8.23 per cent stake in Aster DM...
      Medtronic completes acquisition of Titan Spine

      Medtronic completes acquisition of Titan Spine

      Farhat Nasim30 Jun 2019 9:16 AM IST
      The acquisition of Titan Spine strengthens Medtronic Inc’s position as a leading innovator in procedural solutions for spine surgery.Dublin: Medtronic...
      Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

      Sandoz, Kit Check collaborate to track, automate restocking of products in hospitals

      Farhat Nasim30 Jun 2019 9:12 AM IST
      By collaborating with Kit Check, Sandoz will be able to better understand how its medicines are used in hospitals, optimize the supply chain by...
      Former USFDA boss Scott Gottlieb to join Pfizer board

      Former USFDA boss Scott Gottlieb to join Pfizer board

      Farhat Nasim29 Jun 2019 4:15 PM IST
      Dr Scott Gottlieb is also an elected member of the National Academy of Medicine.New Delhi: Drugmaker Pfizer has recently announced the election of Dr...
      Coming Soon: Common Drug license management for all states via One single software platform

      Coming Soon: Common Drug license management for all states via One single software platform

      Farhat Nasim29 Jun 2019 2:26 PM IST
      New Delhi: In order to achieve hassle-free drug licenses management for all the states in the country, CDSCO committee has decided to bring a have a...
      Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

      Stop use of trademark deceptively similar to Glaxo antibiotic Augmentin: Delhi High Court to AFDIL

      Farhat Nasim29 Jun 2019 11:56 AM IST
      The court's order came on a plea by Glaxo Group Ltd which sought to restrain AFDIL from advertising, marketing or in any manner doing business under...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok